Brain Neurotrauma 2015
DOI: 10.1201/b18126-51
|View full text |Cite
|
Sign up to set email alerts
|

Cranial Nerve Noninvasive Neuromodulation: New Approach to Neurorehabilitation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
28
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 19 publications
(28 citation statements)
references
References 0 publications
0
28
0
Order By: Relevance
“…The TVSS concept was commercialized by Wicab, Inc. (Middleton, WI, USA) in the form of the BrainPort Artificial Vision Device . The BrainPort transmits visual information through an electrotactile display worn on the tongue.…”
mentioning
confidence: 99%
“…The TVSS concept was commercialized by Wicab, Inc. (Middleton, WI, USA) in the form of the BrainPort Artificial Vision Device . The BrainPort transmits visual information through an electrotactile display worn on the tongue.…”
mentioning
confidence: 99%
“…Following artefact rejection, data were processed in order to extract activity speci c to the motor task. The analysis focused on activity in the beta range (13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25)(26)(27)(28)(29)(30). In order to identify the speci c beta frequencies most active during TG's movements, a time-frequency analysis (time locked to the click event and averaged across trials) was performed for each recording session on the electrodes in the contralateral motor area (using a Laplacian spatial lter centered at C3 or C4).…”
Section: Eeg -Motor Functionmentioning
confidence: 99%
“…This phenomenon appears similar to wellknown processes such as long-term potentiation (LTP) and depression. Importantly, when paired with PT (and possibly other forms of intervention), synaptic plasticity may arise through activity-dependent processes to integrate adaptive changes at the molecular, cellular, regional, and systemic levels, which in turn result in a host of improvements in sensory-motor functions, cognitive functions, and behavior (17).…”
Section: Role Of Neuromodulationmentioning
confidence: 99%
See 1 more Smart Citation
“…In 2011, the current BrainPort V100 Oral Electronic Vision Aid was completed (Figure 3(c)). The BrainPort V100 received the CE mark in 2013 [36] and it is since commercially available in Europe. The clinical safety/efficacy study of the BrainPort (NIH clinical trials identifier NCT01488786) [19] showed that there is minimal risk associated with the use of the BrainPort.…”
Section: Development Of the Brainport Artificial Vision Devicementioning
confidence: 99%